Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives.
Murgo
A J
AJ
Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857.
Weinberger
B B
BB
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016465:Bone Marrow Purging / Q000379:methods*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D015394:Molecular Structure; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; C048341:mafosfamide; D003520:Cyclophosphamide; C011272:perfosfamide